
Bill Hayes
Ask VT AI
View News Summary
- BioNTech to acquire German rival CureVac in $1.25B all-stock deal, bolstering its mRNA capabilities.
- Trump administration investigates Minnesota's transgender sports policies after transgender athlete's championship win sparks debate and lawsuits.
- A thrilling T20I match between the Netherlands and Nepal required three Super Overs to decide the winner, setting a new benchmark for dramatic finishes in cricket.
5 days

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- BioNTech to acquire German rival CureVac in $1.25B all-stock deal, bolstering its mRNA capabilities.
- Trump administration investigates Minnesota's transgender sports policies after transgender athlete's championship win sparks debate and lawsuits.
- A thrilling T20I match between the Netherlands and Nepal required three Super Overs to decide the winner, setting a new benchmark for dramatic finishes in cricket.
5 days

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Bill Hayes
News from Bill Hayes